Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2008 1
2010 1
2011 2
2012 3
2013 1
2014 8
2015 3
2016 5
2017 3
2018 5
2019 6
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY. Zhu HT, et al. Among authors: Zhang ZC. Liver Int. 2017 Jun;37(6):888-896. doi: 10.1111/liv.13356. Epub 2017 Feb 3. Liver Int. 2017. PMID: 28061012
Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT, Hasan AM, Liu RB, Zhang ZC, Zhang X, Wang J, Wang HY, Wang F, Shao JY. Zhu HT, et al. Among authors: Zhang ZC, Zhang X. Oncotarget. 2016 Jul 19;7(29):45637-45648. doi: 10.18632/oncotarget.10082. Oncotarget. 2016. PMID: 27317768 Free PMC article.
Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
Zhang T, Yin P, Zhang Z, Xu B, Che D, Dai Z, Dong C, Jiang P, Hong H, Yang Z, Zhou T, Shao J, Xu Z, Yang X, Gao G. Zhang T, et al. Among authors: Zhang Z. Cell Death Dis. 2017 Jun 1;8(6):e2838. doi: 10.1038/cddis.2017.114. Cell Death Dis. 2017. PMID: 28569772 Free PMC article.
Hypermethylation of APC2 Is a Predictive Epigenetic Biomarker for Chinese Colorectal Cancer.
He Y, Sun LY, Wang J, Gong R, Shao Q, Zhang ZC, Ye ZL, Wang HY, Xu RH, Shao JY. He Y, et al. Among authors: Zhang ZC. Dis Markers. 2018 Oct 29;2018:8619462. doi: 10.1155/2018/8619462. eCollection 2018. Dis Markers. 2018. PMID: 30510602 Free PMC article.
First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution's clinical practice experience.
Yu X, Zhang X, Zhang Z, Lin Y, Wen Y, Chen Y, Wang W, Zhang L. Yu X, et al. Among authors: Zhang X, Zhang Z, Zhang L. Cancer Commun (Lond). 2018 Jul 28;38(1):51. doi: 10.1186/s40880-018-0321-0. Cancer Commun (Lond). 2018. PMID: 30055651 Free PMC article.
Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients.
Li ZZ, Bai L, Wang F, Zhang ZC, Wang F, Zeng ZL, Zeng JB, Zhang DS, Wang FH, Wang ZQ, Li YH, Shao JY, Xu RH. Li ZZ, et al. Among authors: Zhang ZC, Zhang DS. Med Oncol. 2016 Jul;33(7):71. doi: 10.1007/s12032-016-0787-z. Epub 2016 Jun 6. Med Oncol. 2016. PMID: 27270901
Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.
Li ZZ, Wang F, Zhang ZC, Wang F, Zhao Q, Zhang DS, Wang FH, Wang ZQ, Luo HY, He MM, Wang DS, Jin Y, Ren C, Qiu MZ, Ren J, Pan ZZ, Li YH, Shao JY, Xu RH. Li ZZ, et al. Among authors: Zhang ZC, Zhang DS. Oncotarget. 2016 May 10;7(19):28356-68. doi: 10.18632/oncotarget.8541. Oncotarget. 2016. PMID: 27050078 Free PMC article. Clinical Trial.
Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.
Wen YS, Cai L, Zhang XW, Zhu JF, Zhang ZC, Shao JY, Zhang LJ. Wen YS, et al. Among authors: Zhang XW, Zhang ZC, Zhang LJ. Medicine (Baltimore). 2014 Dec;93(29):e296. doi: 10.1097/MD.0000000000000296. Medicine (Baltimore). 2014. PMID: 25546673 Free PMC article.
41 results
Jump to page
Feedback